Post by
TSX-BEAR on Jun 30, 2013 9:29pm
How do you explain this....
There is FDA gras approval in the USA and a signed deal from July 2011 with Hormel Century Foods for Isolexx protein isolates and a plant in Ssakatoon near the border of NorthDakota where another plant was in the works yet the only interest has been from Europe where they have to wait for EFSA approval. It come out at the AGM that they were approached by European entity.
Can anyone explain why there is such a discrepancy in these incongruous situations whereby a starter plant has to be sold to pay debt in a North American continent with 300 million population and an approved product only to hope that the EU gets approval while there is a looming cash crunch ?
What am I missing ?
Comment by
1320racing on Jun 30, 2013 11:43pm
This post has been removed in accordance with Community Policy
Comment by
1320racing on Jul 01, 2013 9:17am
This post has been removed in accordance with Community Policy
Comment by
gadfly222 on Jul 01, 2013 2:01pm
.....that would be 'r e p u t a t i o n a l c a p i t a l' ... not sure why this new system created the ******